Claire Sampson

Claire Sampson, PhD has an extensive work experience in the pharmaceutical industry, with their most recent position being the VP Global Regulatory Affairs at Voyager Therapeutics, Inc. Claire joined the company in September 2020 and is currently serving in this role. Prior to that, they worked at Amicus Therapeutics as the Head of Regulatory Gene Therapy from August 2019 to September 2020. From October 2010 to August 2019, they held the position of Director Regulatory Affairs at Novo Nordisk A/S. Before that, they were the Associate Director of Regulatory Affairs at Auxilium Pharmaceuticals from December 2008 to October 2010. Claire also worked as a Manager at PuriCore from October 2005 to December 2008. Claire'searliest work experience was at Pfizer, where they served as a Senior Principal Scientist from 1996 to 2004.

Claire Sampson, PhD, obtained their Ph.D. in Molecular Pharmacology from the University of Aberdeen in the period between 1992 and 1996.